
Cardiac implantable electronic devices such as pacemakers are increasingly encountered in patients presenting for non-cardiac surgery. Their presence poses significant anaesthetic challenges, particularly in low-resource settings where access to device specialists and advanced monitoring may be limited. Careful perioperative planning is therefore essential to minimize complications related to haemodynamic instability and electromagnetic interference. We report the successful anaesthetic management of an 81-year-old male with a permanent pacemaker programmed in DDDR mode who presented for right knee arthrotomy, synovectomy, and washout for septic arthritis. The patient had multiple comorbidities including hypertension, type 2 diabetes mellitus, end-stage renal disease on thrice-weekly haemodialysis, and retroviral disease on highly active antiretroviral therapy. Preoperative evaluation included cardiology consultation, echocardiography demonstrating borderline left ventricular systolic function (ejection fraction 45–52%), and perioperative coordination with a pacemaker technologist who reprogrammed the device to an asynchronous pacing mode. Anaesthesia was conducted using a combined spinal-epidural technique with a low-dose spinal block consisting of 7.5 mg of hyperbaric bupivacaine and 25 µg fentanyl. Standard ASA monitoring was employed, and special precautions were taken to minimize electromagnetic interference from electrocautery by appropriate placement of the diathermy grounding pad. Surgery lasted approximately one hour and was completed without haemodynamic instability, pacemaker malfunction, or other perioperative complications. Postoperative analgesia was provided via the epidural catheter, and the pacemaker was subsequently restored to its original programming. This case highlights the importance of multidisciplinary collaboration, thorough preoperative assessment, and adherence to perioperative safety precautions in managing geriatric patients with pacemakers. It also demonstrates that low-dose spinal anaesthesia can provide adequate surgical conditions with stable haemodynamics for lower limb surgery in selected patients with limited cardiac reserve in resource-constrained settings.
Background Perioperative myocardial injury in elderly hip fracture patients is usually silent and arises mainly from oxygen supply–demand mismatch. Transthoracic echocardiographic coronary sinus blood flow (CSBF) has been proposed as a non-invasive window on coronary perfusion, but its obtainability in this frail population is unknown. This trial assessed whether a definitive trial of PC6 transcutaneous electrical acupoint stimulation (TEAS) using such monitoring is feasible. Methods Three-phase, single-centre, sham-controlled randomised pilot and feasibility trial (June 2023–May 2025). Phase I (n = 30) assessed CSBF obtainability and acute responses to bilateral PC6 TEAS; Phase II (n = 60) explored stimulation parameters in a 2 × 2 factorial (2 vs. 5 Hz; 15 vs. 25 min); Phase III (n = 40) applied the leading combination under standardised total intravenous anaesthesia. Primary outcomes were feasibility outcomes: CSBF obtainability, predictors of measurement failure, recruitment, retention and safety. Clinical measures were secondary and exploratory, and progression criteria were pre-specified. The study was not powered to detect efficacy effects. Results Adequate CSBF spectra were obtainable in 64% of patients (55/85, Phases I–II). Chronic obstructive pulmonary disease (adjusted odds ratio 3.45), body mass index above 25 kg/m 2 (2.87) and thoracic kyphosis (3.21) independently predicted failure; obtainability reached 90.5% when none was present but fell to 56.8% intraoperatively. Recruitment averaged 4.4 patients/month, no patient was lost to follow-up, and no adverse event was attributable to TEAS. Exploratory estimates: coronary sinus velocity–time integral rose 20.8% (95% CI 11.2–30.4) without change in mean arterial pressure; rate-pressure product remained below 12,000 throughout in the TEAS arm, with a pooled between-group separation of 1759 (95% CI 876–2642) at peak-stress time points. Discussion A definitive trial is feasible, but not with transthoracic CSBF as its monitoring backbone: the technique fails in approximately a third of patients, and selectively in those at highest cardiovascular risk. We recommend proceeding with an amended protocol that substitutes pulse-wave analysis. The haemodynamic signals reported here are hypothesis-generating. Trial registration Chinese Clinical Trial Registry (https://www.chictr.org.cn), ChiCTR2600126845; registered 17 June 2026, retrospectively registered. Recruitment ran from June 2023 to May 2025, so registration followed completion of recruitment.
Orthopedic trauma patients with limited mobility and prolonged bed rest are at high risk of venous thromboembolism and pulmonary embolism (PE). When acute hypoxemia and respiratory dysfunction occur in such patients, it is clinically challenging to distinguish PE from acute exacerbation of underlying chronic obstructive pulmonary disease (COPD) or asthma, which directly affects perioperative safety. This study aimed to summarize the diagnostic thinking and standardized anesthetic management strategies for this type of high-risk emergency patient. We reported a 68-year-old male patient diagnosed with L2 burst fracture, who presented with severe hypoxemia (room-air SpO 2 75%) before emergency surgery. Combined with the patient’s medical history, lung auscultation, arterial blood gas analysis and chest computed tomography (CT) findings, we rapidly confirmed that hypoxemia was caused by acute airway obstruction rather than PE. Pre-intubation interventions including bronchodilators, corticosteroids and airway surface anesthesia were applied to prevent intraoperative bronchospasm. Intraoperative lung-protective ventilation was implemented, and stepwise respiratory support was adopted after extubation. The patient had an uneventful perioperative course and was discharged on the 5th postoperative day. In conclusion, for immobilized orthopedic trauma patients complicated with chronic airway diseases and acute respiratory abnormalities, comprehensive differential diagnosis combining clinical manifestations and auxiliary examinations is the premise of safe treatment. Targeted pre-operative prevention, standardized intraoperative ventilation and graded postoperative respiratory care can effectively reduce perioperative respiratory complications.
Background: Fascial plane block (FPB) has gained increasing clinical attention for its favorable safety and operational simplicity, yet its pharmacokinetic profiles and the associated risk of local anesthetic systemic toxicity (LAST) remain inadequately elucidated in clinical practice. Methods: A sample size calculation was performed based on the single-sample proportion formula, with a preset expected non-occurrence rate of LAST of 90%, a margin of error of 10%, and a 95% confidence level, determining a minimum sample size of 14 patients. A retrospective analysis was conducted on 14 patients with hip fracture undergoing total hip arthroplasty (THA) who received ultrasound-guided fascia iliaca compartment block (FICB) with 30 mL of 0.33% ropivacaine (100 mg) from July to September 2024. Plasma ropivacaine concentrations were measured at serial time points via high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS, Agilent 1290-6470, USA), and block-related adverse events were closely monitored. Results: No cases of LAST were observed in all patients. The mean peak plasma concentration (Cmax) of ropivacaine was 0.88±1.13 μg/mL, with a median time to peak concentration (Tmax) of 15 (interquartile range, 6–40) minutes; individual Cmax values ranged from 0.22 to 4.63 μg/mL. Statistical analysis revealed a significant negative correlation between Cmax and body mass index (BMI) (P<0.05), while Tmax showed no significant correlation with clinical characteristics including age and BMI (P>0.05). Conclusion: Ultrasound-guided FICB with 30 mL of 0.33% ropivacaine (100 mg) demonstrates good clinical safety in patients undergoing THA. Marked individual variability exists in plasma ropivacaine concentrations, and Cmax is negatively correlated with patient BMI.
Catheter-related bladder discomfort (CRBD) represents a highly prevalent postoperative complication following general anesthesia. Characterized by suprapubic pain, urinary urgency, and involuntary bladder contractions, CRBD significantly impairs patient recovery and satisfaction. This comprehensive review systematically examines the pathophysiological mechanisms, risk stratification, and evidence-based prevention and treatment strategies for CRBD. The underlying pathogenesis involves muscarinic receptor activation, inflammatory responses, and nociceptor sensitization. Established risk factors encompass patient characteristics, surgical variables, anesthetic factors, and device-related aspects. Multimodal interventions demonstrate superior efficacy, including pharmacological agents such as dexmedetomidine, gabapentin, nefopam, and antimuscarinics; regional anesthesia techniques including pudendal nerve block and sacral erector spinae plane block; and non-pharmacological approaches like transcutaneous electrical nerve stimulation and acupuncture. Technological innovations in catheter design and early removal protocols further enhance recovery outcomes. Future research priorities include external validation of machine learning prediction tools, large-scale comparative effectiveness trials of multimodal bundles, and development of smart catheter systems with integrated biosensing capabilities.